So Clear Protect Protective Treatment
NDC Package 70317-147-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

So Clear Protect Protective Treatment is after using So Clear Cleanse, apply a thin layer to face, nose, or ears and gently rub in. Marketed by Remeverse, this product is identified by NDC 70317-147 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
70317-147-30
Package Description
30 mL in 1 BOTTLE
Product Code
70317-147
11-Digit Billing Format
70317014730

Clinical Specifications

Proprietary Name
So Clear Protect Protective Treatment
Dosage Form
-
Usage Information
After using So Clear Cleanse, apply a thin layer to face, nose, or ears and gently rub in. Allow to dry. Do not wash off. Apply 1 -2 times daily. Discontinue use if increased irritation occurs.

Regulatory & Marketing

Labeler Name
Remeverse
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-31-2021
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70317-147-30 identifies a specific commercial package of 30 ml in 1 bottle of So Clear Protect Protective Treatment, labeled by Remeverse. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Remeverse on March 31, 2021. The current certification is valid through December 31, 2025.

How is this Remeverse product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70317014730. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70317-147-30
11-Digit CMS (5-4-2)
70317-0147-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.